Second primary neoplasms in patients with laryngeal carcinoma

Laryngoscope

Volumn 110, Issue 1, 2000, Pages 58-64

  Nikolaou, Angelos C ^a   Markou, Constantinos D ^a   Petridis, Dimitrios G ^a   Daniilidis, Ioannis C ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Laryngeal carcinoma; Malignancy; Second primary

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER SCREENING; CANCER STAGING; CHILD; HEAD AND NECK CANCER; HUMAN; INFANT; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SECOND CANCER; TREATMENT OUTCOME;

EID: 0033958925     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200001000-00012     Document Type: Article

References (39)

1. Steele GD, Winchester DP, Menck HR, Murphy CP. Clinical highlights from the national cancer database: 1993. CA Cancer J Clin 1993;43:71-82.
2. De Vries N, VanZandwijk N, Pastorino U. The Euroscan study. Br J Cancer 1991;64:985-989.
3. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-456.
4. Billroth T. Die Allgemeine Chirurgische Pathologie und Therapie. Ir 51 Vorlesungen: Ein Handbuch fûr Stuierende und Aerzte. R. Riemer: Berlin, 1882:980.
5. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 1932;16:1358-1414.
6. Rice DH, Spiro RH. Current concepts in head and neck cancer. USA: American Cancer Society 1989:15.
7. Kenneway EL, Kenneway WM. Further study of the incidence of cancer of the lung and larynx. Br J Cancer 1947; 1:260-298.
8. Nikolaou A, Markou K, Daniilidis J. Laryngeal carcinoma. A retrospective study of 420 cases. Hell Iat 1996;62:526-534.
9. Vokes EE, Weichaelbaum RR, Lippman SM, et al. Head and neck cancer. N Engl J Med 1993;328:184-194.
10. Choksi-AJ, Dimery-IW, Hong-WK Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future. Semin Oncol 1988;15(3 Suppl 3):45-59.
11. Sturgis E, Miller R. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995; 104:946-954.
12. Huber M, Lippman S, Hong WK. Chemoprevention of head neck cancer. Semin Oncol 1994;21:366-375.
13. Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol 1984;110:564-565.
14. Benner SE, Lippman SM, Barley C, et al. Long term follow up: 13-cis, retinoic acid (cRA) prevention of second primary tumors (SPT) following squamous cell carcinoma of the head and neck (SCCHN) [abstract]. Proc Am Soc Clin Oncol 1993;12:279.
15. Jones AS, Morar P, Phillips DE, Field-JK, Husband D, Helliwell TR. Second primary tumors in patients with head and neck squamous cell carcinoma. Cancer 1995;75(6): 1343-1353.
16. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications for chemoprevention based on RTOG experience. Int J Radiat Oncol Biol Phys 1989;17: 449-456.
17. Choy AT, van Hasselt CA, Chisholm EM, Williams SR, King WW, Li AK. Multiple primary cancers in Hong Kong Chinese patients with squamous cell cancer of the head or neck Cancer 1992;70(4):815-820.
18. Kleinsasser O and Glanz H. Myogenic tumors of the larynx. Arch Otolaryngol Head Neck Surg 1979;225:207-219.
19. Johnson JT. Carcinoma of the larynx: selective approach to the management of cervical lymphatics. Ear Nose Throat J 1994;73(5):303-305.
20. Wagenfeld DJ, et al. Second primary respiratory tract malignancies in glottic carcinoma. Cancer 1980;46:1883-1886.
21. Boysen M, Loven JO. Second malignant neoplasms in patients with head and neck squamous cell carcinomas. Acta Oncol 1993;32(3):283-288
22. Wagenfeld DJ. Second primary respiratory tract malignant neoplasms in supraglottic carcinoma. Arch Otolaryngol Head Neck Surg 1981;107:135-137.
23. Martin G. Maltiple maligne tumoren bei patienten mit Larynx-Karzinomen. Laryngol Rhinol Otol 1979;58: 756-763.
24. De Vries N. Second primary tumours in laryngeal cancer. Acta Otorhinolaryngol Belg 1992;46:153-159.
25. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990;103(1):14-24.
26. Mc Donald S, Haie C, Rubin P, Nelson D, Divers D. Second malignant tumours in patients with laryngeal carcinoma: diagnosis, treatment and prevention. Int J Radiat Oncol Biol Phys 1989;17:457-465.
27. De Vries N, Snow GB. Multiple primary tumours in laryngeal cancer. J Laryngol Otol 1986;100:915-918.
28. Engelen AM, et al. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otorhinolaryngol 1992;249:364-369.
29. Neugut AI, Sherr D, Robinson E, Murray T, Nieves J. Differences in histology between first and second primary lung cancer. Cancer Epidemiol Biomarkers Prev 1992;1: 109-112.
30. Larson JT, Adams GL, Fattah HA. Survival statistics for multiple primaries in head and neck cancer. Otolaryngol Head Neck Surg 1990;103:14-24.
31. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953; 6:963-968.
32. Farber E. The multistep nature of cancer development. Cancer Res 1984;44:4217-4223.
33. Hsu TC, Spitz MR, Schantz SP. Mutagen sensitivity: a biologic marker or cancer susceptibility. Cancer Epidemiol Biomarkers Prev 1991;1:83-89 .
34. Hsu TC, Shillitoe EJ, Cherry LM, Lin Q, Schantz SP, Furlong C. Cytogenetic characterization of 20 lymphoblastoid lines derived from human individuals differing in bleomycin sensitivity. In Vitro Cell Dev Biol 1990;26:80-84.
35. Schantz SP, Spitz MR, Hsu TC. Mutagen sensitivity in patients with head and neck cancers: a biologic marker for risk of multiple primary malignancies. J Natl Cancer Inst 1990;82:1773-1775.
36. Hsu TC, Johnston DA, Cherry LM. Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 1989;43: 403-409.
37. Schantz SP, Hsu TC, Ainslie N, Moser RR. Young adults with head and neck cancer express increased susceptibility to mutagen-induced chromosome damage. JAMA 1989;262: 3313-3315.
38. DeVries N, Drexhage HA., DeWaal L, DeLange G, Snow GB. Human leukocyte antigens and immunoglobulin allotypes in head and neck cancer patients with and without multiple primary tumors. Cancer 1987;60:957-961.
39. Sporn MB, Dunlop NM, Newton DL, et al. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc 1976;35:1332-1338.